19 results
8-K
EX-99.1
CVSI
CV Sciences, Inc.
28 Mar 24
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results
9:20am
employee retention credit (ERC) under the CARES Act for a total of $2.5 million;
Continued to reduce operating expenses, excluding the benefit from … (Q1 2023);
Received employee retention credit (ERC) under the CARES Act for a total of $2.5 million and extinguished outstanding note payable
8-K
EX-99.1
CVSI
CV Sciences, Inc.
14 Nov 23
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results
12:00am
to cash used in operations of $2.1 million in the first nine months of 2022; cash flow from operations included employee retention credit (ERC) under … by (used in) operating activities:
Depreciation and amortization
Stock-based compensation
Employee retention credit benefit
Note discount and interest
8-K
EX-99.1
ch789q9h3 bi
14 Aug 23
CV Sciences, Inc. Reports Second Quarter 2023 Financial Results
9:32am
8-K
EX-99.1
85fib1kwr5u4k4
15 May 23
CV Sciences, Inc. Reports First Quarter 2023 Financial Results
9:10am
8-K
EX-99.1
pvhd9ohrn11nc00
14 Nov 22
CV Sciences, Inc. Reports Third Quarter 2022 Financial Results
9:12am
8-K
EX-10.3
6ntxbsp9tpd2izym0v
24 Aug 22
Entry into a Material Definitive Agreement
7:04pm
8-K
5f1a6pjb0ic8n
24 Aug 22
Entry into a Material Definitive Agreement
7:04pm
8-K
EX-10.2
42jn4pw6wd7
24 Aug 22
Entry into a Material Definitive Agreement
7:04pm
8-K
EX-99.1
mfw2irk
15 Aug 22
CV Sciences, Inc. Reports Second Quarter 2022 Financial Results
9:06am
8-K
EX-99.1
84o7ocq j9z
16 May 22
CV Sciences, Inc. Reports First Quarter 2022 Financial Results
9:15am
8-K
EX-99.1
wyfqd5c1n2b9 qgta
31 Mar 22
CV Sciences, Inc. Reports Fiscal Year-End 2021 Financial Results
4:10pm
- Prev
- 1
- Next